Session » Systemic Lupus Erythematosus: Clinical Aspects
-
Abstract Number: 602
Sexual and Reproductive Health Counseling Among Adolescents with Systemic Lupus Erythematosus
-
Abstract Number: 603
Cell Bound Complement Activation Products Are Associated with Disease Activity in Systemic Lupus Erythematosus
-
Abstract Number: 604
Comparing the ACR and the SLICC Criteria for the Classification of SLE Patients Using Data from an Existing Multi-Ethnic Cohort
-
Abstract Number: 605
Increased Incidence of Herpes Zoster Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 606
Risk Factors Associated with Cervical Human Papillomavirus Infection in Women with Systemic Lupus Erythematosus: The Role of Rituximab
-
Abstract Number: 607
Activity Index After Renal Failure in a Cohort of 32 Patients with Lupus Nephritis
-
Abstract Number: 608
Association of Discoid Lupus with Other Clinical Manifestations Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 609
Peripheral Neuropathy in Systemic Lupus Erythematosus
-
Abstract Number: 610
B Lymphocyte Stimulator Levels Are Higher in Caucasian SLE Patients Earlier in Disease Course and Predict Damage Accumulation
-
Abstract Number: 611
Impaired Diffusion Tensor Imaging Findings in the Corpus Callosum and Cingulum May Underlie Impaired Learning and Memory Abilities in Systemic Lupus Erythematosus
-
Abstract Number: 612
Thrombosis Recurrence in Systemic Lupus Erythematosus Patients with and without Antiphospholipid Antibodies
-
Abstract Number: 613
Serum Level of Syndecan-1 Is Associated with Disease Activity in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 614
Predictors of Systemic Lupus Erythematosus Flares: Baseline Disease Activity and Demographic Characteristics From the Combined Placebo Groups in the Phase 3 Belimumab Trials
-
Abstract Number: 615
Baseline Laboratory Characteristics From the Combined Placebo Groups in the Phase 3 Belimumab Trials Are Predictive of Severe Flare At 52 Weeks
-
Abstract Number: 616
Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects
-
Abstract Number: 617
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels Reflect Organ Damage in Systemic Lupus Erythematosus
-
Abstract Number: 618
BAFF/BLyS Gene Expression Predicts Disease Activity in Systemic Lupus Erythematosis Over One Year
-
Abstract Number: 619
Elevated Plasma Levels of CXCL2 and CXCL10 Have Distinct Predictive Value in Systemic Lupus Erythematosus
-
Abstract Number: 620
Development of A Quantitative PCR Method to Determine Interferon Signature Metric Status in SLE Patients: Distribution and Clinical & Serological Associations in Two Lupus Clinical Trials
-
Abstract Number: 621
Prolonged Improvement of Systemic Lupus Erythematosus Following Systematic Administration of Rituximab and Cyclophosphamide
-
Abstract Number: 622
Headache in Systemic Lupus Erythematosus (SLE): Results From a Prospective, International, Inception Cohort Study
-
Abstract Number: 623
Endothelial Microparticles As a Biomarker for Endothelial Dysfunction in Active Systemic Lupus Erythematosus
-
Abstract Number: 624
Excess Health Care Utilization Prior to Diagnosis of Systemic Lupus Erythematosus in England
-
Abstract Number: 625
Control of Hypertension and Hypercholesterolemia Is Not Associated with a Decreased Rate of Atherosclerotic Vascular Events in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 627
Zostavax Vaccine Is Safe in Lupus Patients with Low Disease Activity
-
Abstract Number: 628
Urinary Heparanase Activity Is Elevated in Patients with Lupus Nephritis and Correlate with Protein Excretion
-
Abstract Number: 629
Inflammatory Biomarkers of Atherosclerosis and Oxidative Stress Are Associated with Disease Flare in SLE
-
Abstract Number: 630
Risk Factors Associated with Early Central Nervous System Damage Detected Through Diffusion Tensor Imaging (DTI) in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 631
Peripheral Neuropathy Due to Systemic Lupus Erythematosus (SLE) Itself: Incidence, Disease Risk Factors and Outcome
-
Abstract Number: 632
The Effects of Co-Existing Proliferative Histopathology On Membranous Lupus Nephritis
-
Abstract Number: 633
Missed Work Days in Systemic Lupus Erythematosus
-
Abstract Number: 634
Adherence to Adult Treatment Panel III Guidelines for Systemic Lupus Patients
-
Abstract Number: 635
Elevated Transglutaminase Levels On Microparticles From Systemic Lupus Erythematosus Patients
-
Abstract Number: 636
Retrospective Study of Allogenic Mesenchymal Stem Cells Transplantation in Active and Refractory Lupus Nephritis for Induction Therapy
-
Abstract Number: 637
Anti-Mullerian Hormone and Ovarian Reserve in Systemic Lupus Erythematosus
-
Abstract Number: 638
The Progression of Brain MRI Biomarker of Cognitive Impairment (White Matter Hyperintensity) in Systemic Lupus: A Clinical and Imaging Longitudinal Study
-
Abstract Number: 639
Safety and Efficacy of Epratuzumab in an Open-Label Extension Study (SL0006)
-
Abstract Number: 640
Association of Body Weight with Cardiovascular Events in Systemic Lupus Erythematosus
-
Abstract Number: 641
Study of Anti-Müllerian Hormone and Probability of Pregnancy in 112 Systemic Lupus Erythematosus Patients Exposed or Not to Cyclophosphamide
-
Abstract Number: 642
Effects of Treatment On the Expression of CCL2 and CXCL10 in Systemic Lupus Erythematosus Patients
-
Abstract Number: 643
Clinical Characteristics for Future Development of Systemic Lupus Erythematosus in Korean Patients with Idiopathic Thrombocytopenic Purpura
-
Abstract Number: 644
Pulmonary Hypertension in Systemic Lupus Erythematosus: A 6-Year Follow-up Study Cohort
-
Abstract Number: 645
Altered Soluble Inflammatory Mediators Mark Impending Systemic Lupus Erythematosus Disease Flare in European-American Lupus Patients Who Receive Influenza Vaccination
-
Abstract Number: 646
Comparison of the Lupusqol and SF-36 Scores As Valid Measures of Change in Health Related Quality of Life
-
Abstract Number: 647
Adjusted Framingham Risk Factor Scoring for Systemic Lupus Erythematosus: Results from an Inception Cohort Followed for Eight Years
-
Abstract Number: 648
Atherosclerotic Vascular Events in a Multinational Inception Cohort of Systemic Lupus Erythematosus: Incidence Over a Ten Year Period
-
Abstract Number: 649
Increased Male-to-Female Ratio in Children Born to Women with Systemic Lupus Erythematosus
-
Abstract Number: 650
Clinical Variables Associated with Thrombosis At Systemic Lupus Erythematosus Diagnosis. Differences Between Patients with Positive/Negative Lupus Anticoagulant
-
Abstract Number: 651
Suicidal Ideation in Patients with Systemic Lupus Erythematosus: Incidence and Relationship with Anxiety/Depression Score Disease Activity and Organ Damage
-
Abstract Number: 652
Serum Rituximab Levels and Efficiency of B-Cell Depletion: Differences Between Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
-
Abstract Number: 653
Longitudinal Analysis of Plasma Factors and Disease Activity Identifies Von Willebrand Factor As A Biomarker of Lupus Flare
-
Abstract Number: 654
Incidence Studies of Systemic Lupus Erythematosus in Southern Sweden. Have the Tides Turned
-
Abstract Number: 656
Effects of Nelfinavir On Anti-dsDna Antibody Binding and Pro-Inflammatory Cytokine Gene Expression
-
Abstract Number: 657
Serial Screening Shows That 28% of Systemic Lupus Erythematosus Adult Patients Carry an Underlying Primary Immunodeficiency
-
Abstract Number: 1386
Genetic Variation and Coronary Atherosclerosis in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1387
Hospitalizations and Reasons for Admission in a Clinical SLE Cohort
-
Abstract Number: 1388
Diagnostic Accuracy of Anti-dsDNA Antibodies in Unselected Patients with Recent Onset of Rheumatic Symptoms
-
Abstract Number: 1389
Erythrocyte Sedimentation Rate Is a Predictor of Renal and Overall Systemic Lupus Erythematosus Disease Activity
-
Abstract Number: 1390
Vitamin D Deficiency Is Not Associated with Nor Does It Predict Progression of Coronary Artery Calcium or Carotid Intima-Media Thickness in Systemic Lupus Erythematosus
-
Abstract Number: 1391
Anti-Ku Autoantibodies in Systemic Lupus Erythematosus Versus Autoimmune Myositis As Measured by a Novel Chemiluminescence Assay
-
Abstract Number: 1392
Clinical Correlation with Anti Double Stranded Deoxyribonucleic Acid Via Enzyme Linked Immunoassay Versus Multiplex Immunoassay
-
Abstract Number: 1393
Predictors of Panniculitis in Systemic Lupus Erythematosus
-
Abstract Number: 1394
Health Status Burden and Impact of Fatigue On Patient Functioning in SLE Patients From a Phase 1b Study
-
Abstract Number: 1395
The Validation of a New Simple Disease Activity Tool in Systemic Lupus Erythematosus (SLE): The Lupus Activity Scoring Tool (LAST) As Compared to the Sledai Selena Modification
-
Abstract Number: 1396
Associates of a History of Thrombosis in Systemic Lupus Erythematosus
-
Abstract Number: 1397
Risk Factors Associated with Early Central Nervous System Damage Detected Through Perfusion MRI in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1398
Inflammatory Back Pain Is Increased in SLE and Associated with Anti-Sm Antibodies
-
Abstract Number: 1399
Regional Fat Distribution Is Independently Associated with Damage Accrual in Systemic Lupus Erythematosus Female Patients
-
Abstract Number: 1400
Predictors of Obesity in Systemic Lupus Erythematosus
-
Abstract Number: 1401
Characterization of Clinical Photosensitivity in Cutaneous Lupus Erythematosus
-
Abstract Number: 1402
Anti-ApoA1 Antibodies Associate with Disease Activity in Lupus and Are Lower in Patients Taking Hydroxychloroquine: A Longitudinal Analysis of 398 Samples
-
Abstract Number: 1403
Anti-Nucleosome Antibodies Are Associated with Disease Activity and Hydroxychloroquine Use in Patients with Lupus: A Longitudinal, Multivariate Analysis of 398 Samples
-
Abstract Number: 1404
There Is an Association Between Disease Activity and Risk of Thromboembolism in SLE
-
Abstract Number: 1405
Real World Experience Comparing Multiplex Immunobead Assay versus Immunoflorescence Assay for Anti-Nuclear Antibody Detection At a University Hospital
-
Abstract Number: 1406
The Cost of Management of Adult Active Systemic Lupus Erythematosus in the UK
-
Abstract Number: 1407
The Effect of the Antiphospholipid Syndrome (APS) On Survival in Chinese Patients with SLE: A Prospective Study of 679 Patients
-
Abstract Number: 1408
Monitoring Patients with Systemic Lupus Erythematosus in Clinical Practice: Have You Already Checked the Vaccination Status in Your Patients?
-
Abstract Number: 1409
A Multicentre Clinical Study of Umbilical Cord Mesenchymal Stem Cells Transplantation in Active Systemic Lupus Erythematosus
-
Abstract Number: 1410
Relationship Between Individual Organ Damage and Mortality of Systemic Lupus Erythematosus (SLE): A Prospective Cohort Study of 679 Patients
-
Abstract Number: 1411
Equivalence of Various Language Versions of Lupus Specific Patient Reported Outcomes Measure (LupusPRO)
-
Abstract Number: 1412
Vascular Cell Adhesion Molecule (VCAM-1) and Angiostatin in Systemic Lupus Erythematosus
-
Abstract Number: 1413
Clinical Presentation, Treatment and Outcome of Membranous Nephropathy in SLE: A Comparison with Proliferative Lupus Glomerulonephritis in 141 Patients
-
Abstract Number: 1414
Combination of Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis: A 12-Month Open-Labeled Trial
-
Abstract Number: 1415
Effect of Renal Disease On Survival of Patients with Systemic Lupus Erythematosus: A Prospective Cohort Study of 694 Patients
-
Abstract Number: 1416
Tumor Necrosis Factor Alpha Is Associated with Mood Disorders in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1417
Favorable Response to Belimumab At Three Months
-
Abstract Number: 1418
Directed Intuitive Assessment of Lupus (the DIAL system for real world clinics) Correlates Well with BILAG and SLEDAI
-
Abstract Number: 1419
Infections Increase Risk of Arterial and Venous Thromboses in Systemic Lupus Erythematosus Patients: 4925 Patient Years of Follow-up
-
Abstract Number: 1420
Ethnicity and B Cell Depletion Therapy in Systemic Lupus Erythematosus
-
Abstract Number: 1421
Antimalarials Protect Systemic Lupus Erythematosus Patients From Damage Accrual During the First Five Years of the Disease
-
Abstract Number: 1422
Clinical Associations of Anti-Smith Antibodies in Profile: A Multiethnic Lupus Cohort
-
Abstract Number: 1423
Vascular Thrombosis and Pregnancy Morbidity in Patients with Systemic Lupus Erythematosus with Positive Antiphospholipid Profile and Thrombocytopenia
-
Abstract Number: 1424
Prevalence and Clinical Significance of Severe Infection in Patients with Systemic Lupus Erythematosus: Preliminary Data From Relesser (Registry of lupus of the Spanish Society of Rheumatology)
-
Abstract Number: 1425
Circulating Free Protein S Levels May Be Linked to Cardiovascular Events and Venous Thrombosis in SLE
-
Abstract Number: 1426
The Clinical Relevance of a “False Negative” Enzyme Linked Immunoassay: Which Antinuclear Antibody Screening Test Is Preferred by Rheumatologists in an Integrated Health System?
-
Abstract Number: 1427
Late Onset Systemic Lupus Erythematosus: Is It Actually A Milder Variant?
-
Abstract Number: 1428
Long-Term Outcomes of Children Born to Women with Systemic Lupus Erythematosus
-
Abstract Number: 1429
Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Aorta Calcium (AS) Than Women without SLE
-
Abstract Number: 1430
Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Coronary Artery Calcium (CAC)Than Women without SLE
-
Abstract Number: 1431
Single Photon Emission Computed Tomography Contributes to Clinical Assessments in Neuropsychiatric Systemic Lupus Erythematosus Patients
-
Abstract Number: 1432
Safety and Efficacy of Etanercept in Systemic LUPUS Erythematosus
-
Abstract Number: 1433
Persistent Dyslipidemia Is a Risk Factor of Progression to Chronic Kidney Disease in Patients with Lupus Nephritis
-
Abstract Number: 1434
Cardiovascular Morbidity in a Long-Term Follow-up Cohort of Systemic Lupus Erythematosus Patients in Southern Sweden
-
Abstract Number: 1435
Identifying Systemic Lupus Erythematosus Patients At Higher Risk of Coronary Artery Disease
-
Abstract Number: 1437
Majority of Lupusqol Domains Are Negatively Correlated with Systemic Lupus Activity Questionnaire (SLAQ) Score
-
Abstract Number: 2236
Cross Cultural Validation of English and French Versions of a Disease Specific Patient Reported Outcome Measure for Lupus in Canada
-
Abstract Number: 2237
Application and Feasibility of Proposed Systemic Lupus Erythematosus Reproductive Health Care Quality Indicators At a Public Urban Rheumatology Clinic
-
Abstract Number: 2238
Alpha-Chlorofatty Acid Does Not Correlate with Baseline Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus
-
Abstract Number: 2239
Characterization of Pure Membranous Lupus Nephritis: A Cohort of 150 Patients
-
Abstract Number: 2240
Systematic Review of Skin Nontuberculous Mycobacteria Infection in Systemic Lupus Erythematosus: An Unusual Skin Infection Mimicking Lupus Vasculitis
-
Abstract Number: 2241
Efficacy of Belimumab in Systemic Lupus Erythematosus Patients with High Baseline Disease Activity
-
Abstract Number: 2242
Clinical Manifestations and Predictive Factors for Response to Induction Therapy and Maintenance of Remission in ISN/RPS Class V Lupus Nephritis
-
Abstract Number: 2243
A Comparison of Systemic Lupus Erythematosus (SLE) Patients Achieving Prolonged Clinical Quiescence (PCQ) On and off Corticosteroids and/or Immunosuppressive Medications
-
Abstract Number: 2244
Predicting Sjögren’s Syndrome At Diagnosis of Systemic Lupus Erythematosus
-
Abstract Number: 2245
Vitamin D Deficiency Is Associated with, but Does Not Predict, Change in hsCRP in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 2246
Real World Experience with Belimumab in the Management of Systemic Lupus Erythematosus (SLE): A Single Center, Observational, Post-Marketing Study
-
Abstract Number: 2247
The First Report of Desensitization to Trimethoprim/Sulfamethoxazole in Patients with Systemic Lupus Eryhtematosus
-
Abstract Number: 2248
Serum Phosphatidylserine-Specific Phospholipase A1 (PS-PLA1) Identified As a Novel Biomarker for Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 2249
Comparison of Mycophenolate Mofetil and Intravenous Cyclophosphamide As Induction Therapy in Korean Patients with Lupus Nephritis
-
Abstract Number: 2250
A Clinical Analysis of Adult Patients with Autoimmune- and Infection-Associated Hemophagocytic Lymphohistiocytosis
-
Abstract Number: 2251
High Sensitivity C-Reactive Protein, Disease Activity and Cardiovascular Risk Factors in Systemic Lupus Erythematosus
-
Abstract Number: 2252
Epratuzumab-Treated Systemic Lupus Erythematosus Patients Report Improvements in Health-Related Quality of Life: Final Results from an Open-Label Extension Study (SL0006)
-
Abstract Number: 2253
Metabolic Syndrome Is Not Only a Risk Factor for Cardiovascular Events in Systemic Lupus Erythematosus but Also Associated with Cumulative Organ Damage: A Cross-Sectional Analysis of 311 Patients
-
Abstract Number: 2254
Discoid Lupus in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 2255
Apolipoprotein B Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 2256
A Population of IL-21 Producing CD4+ T Cells Correlates with Disease Damage in Systemic Lupus Erythematosus (SLE) Patients
-
Abstract Number: 2257
Association of Low Vitamin D with High Disease Activity in an Australian Systemic Lupus Erythematosus Cohort
-
Abstract Number: 2258
Risk Factors for Total Joint Replacement in Systemic Lupus Erythematosus Patients with Avascular Necrosis
-
Abstract Number: 2259
Limitations of Current Treatment for Systemic Lupus Erythematosus: A Patient and Physician Survey
-
Abstract Number: 2260
Serum DNAse I Anti DNAse I Antibodies , CRP and Antibodies to CRP Relation to Disease Activity in Systemic Lupus Eryhtematous: Longitudinal Studies
-
Abstract Number: 2261
Ovarian Reserve Markers in Reproductive Age Women with Systemic Lupus Erythematosus
-
Abstract Number: 2262
Hypogammaglobulinemia in Pediatric Systemic Lupus Erythematosus
-
Abstract Number: 2263
The Association Between Prior Pregnancy Morbidity and Cardiovascular Events in Women with Systemic Lupus Erythematosus